STADA Arzneimittel AG confirms receipt of another non-binding expression of interest in takeover bid
- Ad hoc Release
- Investor News
Bad Vilbel, February 16, 2017 –
STADA Arzneimittel AG confirms that it has received another legally non-binding conditional expression of interest regarding a bid for the acquisition of up to 100 percent of the shares in the Company at an indicative takeover price of Euro 58.00 per STADA share. STADA is still weighing up its options on how to react in the best interest of the Company. It is not yet possible to foresee whether one or more takeover offers of the three potential bidders will indeed materialise. STADA will keep both the capital markets and the public updated on tangible development in this regard, in line with the applicable legal requirements.
STADA Arzneimittel AG / Investor Relations / Leslie Iltgen / Stadastraße 2–18 / 61118 Bad Vilbel – Germany / Tel.: +49 (0) 6101 603-173 / Fax: +49 (0) 6101 603-215 / E-mail: firstname.lastname@example.org